News

including Dermatomyositis (DM), Polymyositis (PM), Necrotizing myopathy (NM), Inclusion body myositis (IBM), Juvenile forms of myositis (JM), and Antisynthetase syndrome (ASyS). According to The M ...
US-based biotech Abcuro has raised $200m to advance the development of its monoclonal antibody ulviprubart in the rare muscle disease called inclusion body myositis (IBM). The funding round ...